Denise P. Carter
Chief Operating Officer at Quoin Pharmaceuticals Ltd.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Quoin Pharmaceuticals Ltd., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Quoin Pharmaceuticals Ltd. August 20, 202697.7%
-
Quoin Pharmaceuticals Ltd. December 5, 202484.8%
-
Quoin Pharmaceuticals Ltd. October 26, 202389.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Quoin Pharmaceuticals Ltd. | Open-market purchase | +20,490 | $4.88 | $99,991 |
| Dec 23, 2024 | Quoin Pharmaceuticals Ltd. | Open-market purchase | +555,556 | $0.45 | $250,000 |
| Sep 4, 2024 | Quoin Pharmaceuticals Ltd. | Open-market purchase | +8,825 | $0.75 | $6,619 |
| Sep 4, 2024 | Quoin Pharmaceuticals Ltd. | Open-market purchase | +22,988 | $0.80 | $18,390 |
| Sep 3, 2024 | Quoin Pharmaceuticals Ltd. | Open-market purchase | +1,822 | $0.63 | $1,148 |
| Sep 3, 2024 | Quoin Pharmaceuticals Ltd. | Open-market purchase | +4,100 | $0.66 | $2,706 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.